La microbiota intestinal, un ecosistema complejo y dinámico, desempeña un papel crucial en la salud humana. Su influencia se extiende más allá del tracto gastrointestinal, afectando diversas enfer...
Read more
The Technology and Business Forum brings together researchers who will share their knowledge on innovations that are transforming the care of people with diseases such as Alzheimer's or Parkinson's.
Read more
Investigadores de la Universidad Autónoma de Madrid (UAM) han cartografiado, por primera vez, las conexiones del núcleo pulvinar medial, una estructura clave en la comunicación entre distintas regi...
Read more
A team from the Human-Tech Institute has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence
Read more
The round recognizes recent FDA alignment to advance NRTX-1001 into the Phase 3 EPIC (EPIlepsy Cell therapy) trial
Read more
Obstructive sleep apnoea worsens inflammation and oxidative damage (the deterioration of cells) in patients with Alzheimer's disease, according to research led by the Cognition and Behaviour Study Gro...
Read more
La medicina personalizada o de precisión aprovecha los avances biotecnológicos en diversas disciplinas para mejorar el diagnóstico y adaptar las terapias a la singularidad de cada paciente.
Read more
Anaconda Biomed, S.L., a medical technology company developing next generation neurothrombectomy devices, today announced the enrollment and treatment of the first U.S. patient in its ATHENA clinical ...
Read more
The automated analysis of this biomarker, phospho-tau217, is more than 90% effective in identifying patients with Alzheimer's disease. It is an easy-to-use tool that can partly replace other, more com...
Read more
Results of a VHIO led study show that up to 90% of chronically hypoxic patients have an EPAS1 alteration in their tumor, a gene critical for adapting to lack of oxygen in populations living at high-al...
Read more
The work has led to the development of a new assessment scale called the ‘Girona Score’, which helps identify patients at greater risk of disability during the three months following the acute pha...
Read more
The funding will drive two preclinical development programs for its groundbreaking drug, ACT-02—an innovative compound with potential disease-modifying properties. ACT-02 functions as an inhibitor o...
Read more
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
Telum Therapeutics, a biotechnology company leveraging proprietary met...
